Q1 Earnings Forecast for ANIK Issued By Barrington Research
Anika Therapeutics, Inc. (NASDAQ:ANIK – Free Report) – Barrington Research issued their Q1 2026 earnings estimates for shares of Anika Therapeutics in a research report issued on Thursday, March 13th. Barrington Research analyst M. Petusky expects that the biotechnology company will earn ($0.16) per share for the quarter. Barrington Research has a “Outperform” rating and […]
